Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Toll Brothers, a leading luxury home builder, announced the upcoming launch of Ridge at Granite Highlands, a new luxury home community in Washougal, Washington. The community will feature upscale homes with modern designs and scenic views, with sales beginning in November 2026. This expansion underscores Toll Brothers' commitment to growing its foo…
All In FutureTech Alliance Inc. (Nasdaq: AIFA) is hosting its 2026 Annual Gathering on October 3-4, 2026, in Las Vegas. The event includes a Chairman's keynote unveiling the company's annual strategy focused on AI-driven business and service platform development targeting global Chinese communities, alongside Q&A sessions, and showcases through fou…
Workhorse Group Inc. announced a follow-on purchase order from Gateway Fleets for 200 W56 all-electric step vans, expanding their ongoing partnership to support last-mile delivery operators through leasing programs bundled with charging infrastructure. The expansion reflects growing demand for electric commercial vehicles and aims to provide cost s…
BayFirst Financial Corp., a Florida-based registered bank holding company, announced it will release its third quarter 2026 financial results after market close on October 29, followed by a management conference call on October 30. The announcement provides details about the webcast and participation instructions. The company highlighted its assets…
Allarity Therapeutics announced recent patent awards and CLIA certification for its proprietary Drug Response Predictor (DRP) technology, enhancing its clinical development and commercial exclusivity of stenoparib, a dual PARP and WNT pathway inhibitor. The DRP test's correlation with longer overall survival in ovarian cancer patients supports its …
Elevra Lithium Limited, a North American lithium producer listed on ASX and NASDAQ, has announced key dates for its 2026 Annual General Meeting, including director nominations and the release of the Notice of Meeting. Shareholders will receive information on participation closer to the meeting date.
OneMedNet Corporation has signed a seven-figure, multiyear agreement to provide de-identified, multimodal clinical Real World Data through its iRWD™ platform to an AI-enabled precision medicine company. The agreement includes recurring sublicensing revenue opportunities and options to expand data volume and contract value, strengthening OneMedNet's…
LPL Financial has announced that the financial advisors from Lakewood Wealth Management have joined its broker-dealer and Registered Investment Advisor platforms. The Lakewood team brings approximately $170 million in assets under management. The move enhances LPL's advisory capabilities and provides Lakewood's clients with access to LPL's technolo…
Mondelez (MDLZ) is offering a compelling long-term entry after a recent pullback. The snack giant combines a $75.7B market cap, $3.09B in free cash flow, a 3.3% dividend yield and raised organic sales guidance. Technical indicators show near-oversold conditions while valuation is reasonable versus its cash generation. This idea outlines a concrete …
Peoples Bancorp Inc. (NASDAQ: PEBO) has agreed to acquire Capital Bancorp, Inc. (NASDAQ: CBNK) in an all-stock merger valued at approximately $728.1 million. The combined entity will have about $14 billion in assets and a diversified portfolio including community banking, commercial banking, digital consumer credit, and mortgage businesses. The dea…
Silo Pharma, a US-based developmental-stage biopharmaceutical company, announced enhancements to its AI agent subsidiary QwikAgents' platform by incorporating support for NVIDIA Nemotron models and introducing a new Hermes agent runtime alongside the existing OpenClaw runtime. These updates provide customers greater flexibility in AI model and soft…
Marvell is cheaper now than it was in August and still sitting in the AI/optics sweet spot. Fundamentals show strong growth and healthy liquidity, but the stock trades at lofty multiples vs. cash flows and carries meaningful customer concentration and execution risk. This trade targets a mid-term rally while keeping a tight stop to manage re-rating…
Q/C Technologies announces a research collaboration with Sandia National Laboratories' Center for Integrated Nanotechnologies to advance its optical processing unit (OPU) initiative aimed at enhancing AI inference through nanophotonics. This partnership leverages Sandia’s extensive expertise in photonics and nanoscale technologies to develop scalab…
Beacon Financial Corporation (NYSE: BBT), a regional bank based in Boston with $22.3 billion in assets, announced it will release its third quarter 2026 earnings on October 21, 2026, followed by a management conference call on October 22, 2026. The company provides a wide range of banking services across New England and New York, including commerci…
SUNation Energy Inc. announced that CEO Scott Maskin will speak at the HIA-LI Energy Conference focusing on the increasing electricity demand, new state energy policies including renewable requirements for new buildings, and opportunities for distributed energy resources. The company's leadership involvement highlights growth prospects amid evolvin…
AIM ImmunoTech discusses the potential of its drug Ampligen® to complement new pancreatic cancer treatments by enhancing the innate immune response. Encouraging survival data from a Dutch Named Patient Program and an ongoing Phase 2 DURIPANC study investigating Ampligen in combination with AstraZeneca's durvalumab support further clinical developme…
Ernexa Therapeutics announced positive results from three key IND-enabling safety studies of ERNA-101, its lead cell therapy for ovarian cancer. The repeat-dose GLP toxicology study revealed no adverse findings at any dose, the tumorigenicity study showed no teratoma formation over six months, and biodistribution analysis confirmed targeted tumor d…
Oracle is trading at $137.90 with a ~$417B market cap after headlines around Project Jupiter delays and massive near-term capex. The company booked $30B+ in new AI cloud contracts, RPO of $664B and Cloud Infrastructure revenue up 121% to $7.4B. Negative free cash flow and heavy capex are real, but valuation metrics (EV/EBITDA ~14.3, P/E ~22) still …
Decoy Therapeutics, a NASDAQ-listed biotechnology company specializing in designing multi-antiviral peptides across viral families, announced that CEO Rick Pierce will present at The Small Cap Showcase in New York City. The presentation will cover corporate overview and investor meetings, highlighting their AI-driven IMP³ACT platform and lead antiv…
Battalion Oil Corporation announced the release of its updated September 2026 investor presentation, detailing its strategic priorities, Delaware Basin asset portfolio, financial position, and outlook through 2027. The company highlighted its balance-sheet improvements, capital-efficient growth plans, and commitment to transparent investor communic…
Skyworks Solutions, Inc. announced receiving all necessary regulatory approvals to proceed with its previously announced merger with Qorvo, Inc. The transaction, expected to close around October 5, 2026, will combine their complementary technologies to form a leading U.S.-based global player in high-performance radio frequency, analog, and mixed-si…
TOMI Environmental Solutions announced that Project MEND, a nonprofit refurbishing and redistributing medical equipment, is using TOMI's SteraMist ionized hydrogen peroxide (iHP) technology to disinfect durable medical equipment such as wheelchairs, hospital beds, and mobility aids before reuse. This partnership highlights SteraMist's capability to…
Candel Therapeutics disclosed novel data from phase 2 and phase 3 trials showing that aglatimagene besadenovec, combined with external beam radiation therapy, induces durable local and systemic immune activation in intermediate-risk localized prostate cancer. The phase 3 trial demonstrated significant reductions in risk of recurrence and metastasis…
SEALSQ Corp, a US-listed company specializing in semiconductors and post-quantum cybersecurity, emphasizes the capabilities of its French subsidiary IC'Alps in designing custom, low-power, secure ASICs tailored for implantable and connected medical devices. The acquisition strengthens SEALSQ's position in the growing medical electronics market by c…
Autonomix Medical announced positive feedback from the FDA indicating a potential Class II 510(k) clearance pathway leveraging substantial equivalence to an already-cleared device for its standalone transvascular sensing platform. The company targets U.S. clearance in approximately 15 months, which marks a significant step toward commercializing it…
